341 related articles for article (PubMed ID: 27697976)
1. NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
Clark PE; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Efstathiou JA; Flaig TW; Friedlander T; Greenberg RE; Guru KA; Hahn N; Herr HW; Hoimes C; Inman BA; Kader AK; Kibel AS; Kuzel TM; Lele SM; Meeks JJ; Michalski J; Montgomery JS; Pagliaro LC; Pal SK; Patterson A; Petrylak D; Plimack ER; Pohar KS; Porter MP; Sexton WJ; Siefker-Radtke AO; Sonpavde G; Tward J; Wile G; Dwyer MA; Smith C
J Natl Compr Canc Netw; 2016 Oct; 14(10):1213-1224. PubMed ID: 27697976
[TBL] [Abstract][Full Text] [Related]
2. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Chang S; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Guzzo T; Herr HW; Hoffman-Censits J; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Michalski J; Montgomery JS; Nandagopal L; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wright JL; Gurski LA; Johnson-Chilla A
J Natl Compr Canc Netw; 2020 Mar; 18(3):329-354. PubMed ID: 32135513
[TBL] [Abstract][Full Text] [Related]
3. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
[TBL] [Abstract][Full Text] [Related]
4. Intravesical bacillus Calmette-Guérin instillation in non-muscle-invasive bladder cancer: A review.
Saluja M; Gilling P
Int J Urol; 2018 Jan; 25(1):18-24. PubMed ID: 28741703
[TBL] [Abstract][Full Text] [Related]
5. Intravesical therapy for bladder cancer.
Patel SG; Cohen A; Weiner AB; Steinberg GD
Expert Opin Pharmacother; 2015 Apr; 16(6):889-901. PubMed ID: 25773220
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Mohler JL; Armstrong AJ; Bahnson RR; Boston B; Busby JE; D'Amico AV; Eastham JA; Enke CA; Farrington T; Higano CS; Horwitz EM; Kantoff PW; Kawachi MH; Kuettel M; Lee RJ; MacVicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Roach M; Rohren E; Rosenfeld S; Srinivas S; Strope SA; Tward J; Twardowski P; Walsh PC; Ho M; Shead DA
J Natl Compr Canc Netw; 2012 Sep; 10(9):1081-7. PubMed ID: 22956807
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria: A Systematic Review.
Poletajew S; Zapała P; Radziszewski P
Urol Int; 2017; 99(1):1-5. PubMed ID: 28601885
[TBL] [Abstract][Full Text] [Related]
8. Developments in intravesical therapy for non-muscle-invasive bladder cancer.
Lammers RJ; Witjes JA
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1903-16. PubMed ID: 21110757
[TBL] [Abstract][Full Text] [Related]
9. Superficial bladder cancer: part 2. Management.
Josephson D; Pasin E; Stein JP
Expert Rev Anticancer Ther; 2007 Apr; 7(4):567-81. PubMed ID: 17428176
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
[TBL] [Abstract][Full Text] [Related]
11. Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.
Nepple KG; Lightfoot AJ; Rosevear HM; O'Donnell MA; Lamm DL;
J Urol; 2010 Nov; 184(5):1915-9. PubMed ID: 20846688
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis.
Boehm BE; Cornell JE; Wang H; Mukherjee N; Oppenheimer JS; Svatek RS
J Urol; 2017 Sep; 198(3):503-510. PubMed ID: 28286068
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
Evans CP
Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
[No Abstract] [Full Text] [Related]
14. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
Turker P; Turkeri L
Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.
Farina MS; Lundgren KT; Bellmunt J
Drugs; 2017 Jul; 77(10):1077-1089. PubMed ID: 28493171
[TBL] [Abstract][Full Text] [Related]
16. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
Huang Z; Liu H; Wang Y; Zhang C; Xu T
Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
[TBL] [Abstract][Full Text] [Related]
17. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
18. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravesical bacillus Calmette-Guérin plus interferon α-2b therapy for nonmuscle invasive bladder cancer in patients with prosthetic devices.
Rosevear HM; Lightfoot AJ; Nepple KG; O'Donnell MA
J Urol; 2010 Nov; 184(5):1920-4. PubMed ID: 20846678
[TBL] [Abstract][Full Text] [Related]
20. Valrubicin in refractory non-muscle invasive bladder cancer.
Sharma P; Zargar-Shoshtari K; Sexton WJ
Expert Rev Anticancer Ther; 2015; 15(12):1379-87. PubMed ID: 26569509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
